ImmunoPrecise

ImmunoPrecise Antibodies (IPA) is an advanced biotherapeutic research and technology company utilizing artificial intelligence, high-throughput screening, and multi-species antibody discovery platforms. IPA delivers full-service, end-to-end therapeutic antibody discovery and engineering solutions, assisting global pharmaceutical clients in moving from target identification to optimized, developable lead candidates.